Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Merge Healthcare Company Profile (NASDAQ:MRGE)

Consensus Ratings for Merge Healthcare (NASDAQ:MRGE) (?)
Ratings Breakdown: 2 Sell Rating(s), 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 1.80)
Consensus Price Target: $3.08 (27.94% upside)

Analysts' Ratings History for Merge Healthcare (NASDAQ:MRGE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/15/2014EVA DimensionsUpgradeUnderweight -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/24/2014ZacksDowngradeNeutral -> Underperform$2.25ViewTweet This Rating  Share This Rating on StockTwits
12/17/2013ZacksReiterated RatingNeutral -> Neutral$2.50ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013ZacksReiterated RatingNeutral -> Neutral$3.00ViewTweet This Rating  Share This Rating on StockTwits
8/30/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
8/13/2013ZacksReiterated RatingNeutral -> Neutral$2.50ViewTweet This Rating  Share This Rating on StockTwits
8/12/2013Robert W. BairdLower Price TargetOutperform$7.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2013Craig HallumDowngradeBuy -> Hold$3.75 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2013Robert W. BairdBoost Price TargetOutperform$5.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
7/12/2013ZacksReiterated RatingNeutral -> Neutral$4.25ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013ZacksReiterated RatingNeutral -> Neutral$3.25ViewTweet This Rating  Share This Rating on StockTwits
5/2/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
4/3/2013Craig HallumUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
4/2/2013ZacksReiterated RatingNeutral -> Neutral$3.25ViewTweet This Rating  Share This Rating on StockTwits
3/28/2013B. RileyInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
2/21/2013ZacksReiterated RatingNeutral -> Neutral$2.50ViewTweet This Rating  Share This Rating on StockTwits
2/19/2013Dougherty & CoUpgradeNeutral -> Buy$3.50ViewTweet This Rating  Share This Rating on StockTwits
2/19/2013Dougherty & CoUpgradeNeutral -> Buy$3.50ViewTweet This Rating  Share This Rating on StockTwits
11/21/2012ZacksReiterated RatingNeutral -> Neutral$2.75ViewTweet This Rating  Share This Rating on StockTwits
11/2/2012Craig HallumDowngradeBuy -> Hold$4.50 -> $3.75ViewTweet This Rating  Share This Rating on StockTwits
9/20/2012Robert W. BairdReiterated RatingOutperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
9/7/2012Dougherty & CoDowngradeBuy -> Neutral$5.00 -> $3.25ViewTweet This Rating  Share This Rating on StockTwits
9/6/2012ZacksReiterated RatingNeutral -> Neutral$3.50ViewTweet This Rating  Share This Rating on StockTwits
7/9/2012Craig HallumUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
6/19/2012ZacksReiterated RatingNeutral -> Neutral$2.50ViewTweet This Rating  Share This Rating on StockTwits
5/11/2012Imperial CapitalLower Price TargetOutperform$8.50 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/16/2012 forward)